A detailed history of Geode Capital Management, LLC transactions in Verrica Pharmaceuticals Inc. stock. As of the latest transaction made, Geode Capital Management, LLC holds 455,480 shares of VRCA stock, worth $3.62 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
455,480
Previous 463,362 1.7%
Holding current value
$3.62 Million
Previous $3.38 Million 7.23%
% of portfolio
0.0%
Previous 0.0%

Shares

25 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

SELL
$7.95 - $7.95 $62,661 - $62,661
-7,882 Reduced 1.7%
455,480 $3.62 Million
Q2 2024

Aug 09, 2024

BUY
$5.89 - $9.56 $82,772 - $134,346
14,053 Added 3.13%
463,362 $3.38 Million
Q1 2024

May 13, 2024

BUY
$4.74 - $6.81 $93,055 - $133,693
19,632 Added 4.57%
449,309 $2.66 Million
Q4 2023

Feb 13, 2024

BUY
$2.93 - $7.32 $37,758 - $94,332
12,887 Added 3.09%
429,677 $3.15 Million
Q3 2023

Nov 13, 2023

BUY
$3.75 - $7.46 $106,061 - $210,991
28,283 Added 7.28%
416,790 $1.62 Million
Q2 2023

Aug 11, 2023

BUY
$5.32 - $6.79 $1.1 Million - $1.41 Million
207,624 Added 114.78%
388,507 $2.24 Million
Q1 2023

May 15, 2023

BUY
$2.88 - $8.51 $51,609 - $152,499
17,920 Added 11.0%
180,883 $1.18 Million
Q4 2022

Feb 13, 2023

BUY
$2.09 - $3.39 $26,601 - $43,147
12,728 Added 8.47%
162,963 $448,000
Q3 2022

Nov 14, 2022

BUY
$2.17 - $4.3 $63,127 - $125,091
29,091 Added 24.01%
150,235 $438,000
Q2 2022

Aug 12, 2022

SELL
$1.81 - $8.93 $174,219 - $859,548
-96,254 Reduced 44.28%
121,144 $232,000
Q1 2022

May 13, 2022

SELL
$7.59 - $9.49 $3,263 - $4,080
-430 Reduced 0.2%
217,398 $1.76 Million
Q4 2021

Feb 11, 2022

SELL
$9.1 - $13.36 $184,193 - $270,419
-20,241 Reduced 8.5%
217,828 $2 Million
Q3 2021

Nov 12, 2021

BUY
$9.55 - $13.96 $239,599 - $350,242
25,089 Added 11.78%
238,069 $2.98 Million
Q2 2021

Aug 13, 2021

BUY
$9.77 - $15.33 $135,040 - $211,891
13,822 Added 6.94%
212,980 $2.41 Million
Q1 2021

May 12, 2021

BUY
$10.51 - $17.46 $151,259 - $251,284
14,392 Added 7.79%
199,158 $3.02 Million
Q4 2020

Feb 12, 2021

SELL
$7.41 - $12.63 $11,537 - $19,664
-1,557 Reduced 0.84%
184,766 $2.13 Million
Q3 2020

Nov 13, 2020

SELL
$6.16 - $10.3 $68,967 - $115,318
-11,196 Reduced 5.67%
186,323 $1.44 Million
Q2 2020

Aug 13, 2020

BUY
$9.02 - $15.12 $157,435 - $263,904
17,454 Added 9.69%
197,519 $2.17 Million
Q1 2020

May 14, 2020

BUY
$7.14 - $16.86 $120,166 - $283,753
16,830 Added 10.31%
180,065 $1.97 Million
Q4 2019

Feb 13, 2020

BUY
$13.08 - $17.43 $255,190 - $340,059
19,510 Added 13.57%
163,235 $2.59 Million
Q3 2019

Nov 12, 2019

BUY
$8.65 - $14.81 $534,578 - $915,272
61,801 Added 75.44%
143,725 $2.12 Million
Q2 2019

Aug 14, 2019

BUY
$7.1 - $11.62 $144,421 - $236,362
20,341 Added 33.03%
81,924 $951,000
Q1 2019

May 14, 2019

BUY
$7.95 - $14.07 $196,182 - $347,205
24,677 Added 66.86%
61,583 $665,000
Q4 2018

Feb 13, 2019

BUY
$6.75 - $16.12 $59,973 - $143,226
8,885 Added 31.71%
36,906 $300,000
Q3 2018

Nov 13, 2018

BUY
$13.94 - $19.88 $390,612 - $557,057
28,021 New
28,021 $455,000

Others Institutions Holding VRCA

About Verrica Pharmaceuticals Inc.


  • Ticker VRCA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 41,094,100
  • Market Cap $327M
  • Description
  • Verrica Pharmaceuticals Inc., a dermatology therapeutics company, develops and commercializes treatments for people with skin diseases in the United States. The company's lead product candidate includes VP-102 for the treatment of molluscum contagiosum; that has completed Phase II clinical trial for the treatment of external genital warts; and w...
More about VRCA
Track This Portfolio

Track Geode Capital Management, LLC Portfolio

Follow Geode Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Geode Capital Management, LLC with notifications on news.